kras mutation and glutathion KRAS-targeted therapies in cancer: novel approaches overcoming resistance KRAS-Mutant Lung Cancer: Targeting Molecular
KRAS Mutant Lung Cancer: Targeting Molecular and Immunologic Pathways, Therapeutic Advantages and Restrictions PMC BRAFV600E in colorectal cancer reduces sensitivity to oxidative stress and promotes site specific metastasis by stimulating glutathione synthesis: Cell Reports Uncovering new therapeutic targets for a common KRAS mutation behind cancer KRAS OriGene Technologies Inc. Mechanisms of Resistance to KRAS Inhibitors: Cancer Cells' Strategic Use of Normal Cellular Mechanisms to Adapt Tanaka 2025 Cancer Science Wiley Online Library
Pay in 4 interest-free payments of $6.69 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9




